Acute and chronic administration of disodium disuccinate astaxanthin (Cardax™) produces marked cardioprotection in dog hearts

Molecular and Cellular Biochemistry

Volumn 272, Issue 1-2, 2005, Pages 221-227

  Gross, Garrett J ^a   Lockwood, Samuel F ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HAWAII BIOTECH INC   (United States)

Author keywords

Astaxanthin; Canine infarct model; Cardax ; Cardioprotection; Carotenoids; Disodium disuccinate astaxanthin; Infarct size; Myocardial salvage

Indexed keywords

CARDAX; CAROTENOID; DISODIUM DISUCCINATE ASTAXANTHIN; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG BLOOD LEVEL; FOLLOW UP; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; REPERFUSION;

ANIMALS; BETA CAROTENE; CARDIOTONIC AGENTS; DOGS; HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; SUCCINATES; XANTHOPHYLLS;

ANIMALIA; CANIS FAMILIARIS; RODENTIA;

EID: 20944444610     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-7555-2     Document Type: Article

References (30)

1. Britton G: Structure and properties of carotenoids in relation to function. FASEB J 9: 1551-1558, 1995 1:CAS:528:DyaK28XhsVCksw%3D%3D
2. G Britton S Liaaen-Jensen H Pfander AZ Mercadante ES Egeland (eds) 2004 Carotenoids Handbook Birkhäuser Basel
3. Oliveros E, Braun AM, Aminian-Saghafi T, Sliwka HR: Quenching of singlet oxygen by carotenoid derivatives: Kinetic analysis by near-infrared luminescence. New J Chem 18: 535-539, 1994 1:CAS:528:DyaK2cXmtFOgs7Y%3D
4. Burton GW, Ingold KU: Beta-carotene: An unusual type of lipid antioxidant. Science 224: 569-573, 1984 1:CAS:528:DyaL2cXktVantrs%3D
5. Cardounel AJ, Dumitrescu C, Zweier JL, Lockwood SF: Direct superoxide anion scavenging by a disodium disuccinate astaxanthin derivative: Relative efficacy of individual stereoisomers versus the statistical mixture of stereoisomers by electron paramagnetic resonance imaging. Biochem Biophys Res Commun 307: 704-712, 2003 10.1016/ S0006-291X(03)01248-8
6. Jackson HL, Cardounel AJ, Zweier JL, Lockwood SF: Synthesis, characterization, and direct aqueous superoxide anion scavenging of a highly water-dispersible astaxanthin-amino acid conjugate. Bioorg Med Chem Lett 14: 3985-3991, 2004 10.1016/j.bmcl.2004.05.038
7. Frey DA, Kataisto EW, Ekmanis JL, O'Malley S, Lockwood SF: The efficient synthesis of disodium disuccinate astaxanthin (Cardax). Org Process Res Dev 8: 796-801, 2004 10.1021/op049909i
8. Zsila F, Simonyi M, Lockwood SF: Interaction of the disodium disuccinate derivative of meso-astaxanthin with human serum albumin: From chiral complexation to self-assembly. Bioorg Med Chem Lett 13: 4093-4100, 2003 1:CAS:528:DC%2BD3sXosVWrtrY%3D
9. Gross GJ, Lockwood SF: Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax™). Life Sci 75: 215-224, 2004 1:CAS:528:DC%2BD2cXjs1Wktbw%3D
10. Østerlie M, Bjerkeng B, Liaaen-Jensen S: Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin(1). J Nutr Biochem 11: 482-490, 2000 11120445
11. Showalter LA, Weinman SA, Østerlie M, Lockwood SF: Plasma appearance and tissue accumulation of non-esterified, free astaxanthin in c57bly6 mice after oral dosing of a disodium disuccinate diester of astaxanthin (Heptax™). Comp Biochem Physiol C Toxicol Pharmacol 137: 227-236, 2004 15171947
12. Mizumura T, Auchampach JA, Linden J, Bruns RF, Gross GJ: PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res 79: 415-423, 1996 1:CAS:528:DyaK28XlsVOgu7s%3D
13. Mizumura T, Nithipatikom K, Gross GJ: Infarct size-reducing effect of nicorandil is mediated by the K ATP channel but not by its nitrate-like properties in dogs. Cardiovasc Res 32: 274-285, 1996 1:CAS:528:DyaK28XlsVahu7s%3D
14. O'Keefe JH Jr, Grines CL, DeWood MA, Bateman TM, Christian TF, Gibbons RJ: Factors influencing myocardial salvage with primary angioplasty. J Nucl Cardiol 2: 35-41, 1995 9420760
15. Kopecky SL, Aviles RJ, Bell MR, Lobl JK, Tipping D, Frommell G, Ramsey K, Holland AE, Midei M, Jain A, Kellett M, Gibbons RJ: AMP-579 delivery for myocardial infarction reduction study. Am Heart J 146: 146-152, 2003 1:CAS:528:DC%2BD3sXltF2isrw%3D
16. Auchampach JA, Grover GJ, Gross GJ: Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 26: 1054-1062, 1992 1:CAS:528:DyaK3sXlt1WksQ%3D%3D
17. Auchampach JA, Maruyama M, Cavero I, Gross GJ: Pharmacological evidence. For a role of ATP-dependent potassium channels in myocardial stunning. Circulation 86: 311-319, 1992 1:CAS:528:DyaK38XmtlWgt74%3D
18. Auchampach JA, Cavero I, Gross GJ: Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol 20: 765-771, 1992 1:CAS:528:DyaK3sXhs1Sntw%3D%3D
19. Curry S, Brick P, Franks NP: Fatty acid binding to human serum albumin: New insights from crystallographic studies. Biochim Biophys Acta 1441: 131-140, 1999 1:CAS:528:DyaK1MXns1Sgs7Y%3D
20. Miki W: Biological functions and activities of animal carotenoids. Pure Appl Chem 63: 141-146, 1991 1:CAS:528:DyaK3MXht1SmsLc%3D
21. Hix LM, Lockwood SF, Bertram JS: Upregulation of connexin 43 protein expression and increased gap junctional communication by water soluble disodium disuccinate astaxanthin derivatives. Cancer Lett 211: 25-37, 2004 1:CAS:528:DC%2BD2cXkvVKrtrg%3D
22. Kurihara H, Koda H, Asami S, Kiso Y, Tanaka T: Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci 70: 2509-2520, 2002 1:CAS:528:DC%2BD38Xks1ymu7k%3D
23. Foss BJ, Sliwka HR, Partali V, Cardounel AJ, Zweier JL, Lockwood SF: Direct superoxide anion scavenging by a highly water-dispersible carotenoid phospholipid evaluated by electron paramagnetic resonance (EPR) spectroscopy. Bioorg Med Chem Lett 14: 2807-2812, 2004 1:CAS:528:DC%2BD2cXjs1amtLo%3D
24. Bertram JS: Carotenoids and gene regulation. Nutr Rev 57: 182-191, 1999 1:STN:280:DyaK1MzmvVCrtA%3D%3D
25. Hix LM, Lockwood SF, Bertram JS: Bioactive carotenoids: Potent antioxidants and regulators of gene expression. Redox Rep 9: 181-191, 2004 1:CAS:528:DC%2BD2cXhtVyit7rI
26. Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, Han JA, Yim SV, Chang K, Kwon YG, Lee SK, Kim YM: Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappab activation. Mol Cells 16: 97-105, 2003 1:CAS:528:DC%2BD3sXnvFOgt7Y%3D
27. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S: Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 44: 2694-2701, 2003 10.1167/ iovs.02-0822
28. Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM: Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol 37: 919-948, 2004
29. Singh RB, Singh NK, Rastogi SS, Wander GS, Aslam M, Onouchi Z, Kummerow FA, Nangia S: Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits. Cardiovasc Drugs Ther 11: 575-580, 1997 1:CAS:528:DyaK1cXjvF0%3D
30. Aoi W, Naito Y, Sakuma K, Kuchide M, Tokuda H, Maoka T, Toyokuni S, Oka S,Yasuhara M, Yoshikawa T: Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal 5: 139-144, 2003 1:CAS:528:DC%2BD3sXhslGrsLw%3D